ICSTI Statement on Nanotechnology - Forfás

More documents

Recommendations

Info

Currently, this sector is comprised of a large number of start-ups, spun-out from leading academic research groups, and a growing number of new business units within the materials and fine chemicals multinationals. While the number of nanotools and nanomaterials companies, indigenous or multinational, currently based in Ireland is relatively small; the Task Force is aware of a significant number of individuals and groups seeking funding to establish start-ups in this area, and a number of multinational companies seeking to locate in Ireland. For reasons of commercial confidentiality, it is not possible to describe these opportunities in more details. Figure 5.1: Deerac Fluidics spot-on technology allows liquid handling in the 20 nanolitre to 2 microlitre range. Deerac Fluidics has developed an innovative liquid handling technology designed to have a broad range of applications. The proprietary spot-on technology allows for the deposition of a wide range of 20 nL to 20 µL. This product has been developed to meet a strong market drive in the pharmaceutical, biotechnology and analytical sectors towards miniaturisation, the use of smaller volumes of reagents and biological materials. The driving forces for this shift are two fold. Firstly the reduction of operating costs by lowering the volume of expensive reagents and secondly reducing product development schedules. Deerac Fluidics is supplying an enabling solution to address this need and has developed a global market leading business in the genomics and proteomics areas. 25
26 5.3 Improved Products and Processes There exists a large and rapidly growing number of products and process that have been or that are capable of being improved by utilising nanotools or incorporating nanomaterials. Nanotools are increasingly being used to establish the relationship between the structure of the materials used to manufacture a product and the performance and cost of the product. They are also increasingly being used to optimise and control the processes that are used to manufacture the above products. In the case of small companies, these nanotools are often accessed, at least initially, through national or regional centres linked to third level institutions or national laboratories. Nanomaterials, possessing novel properties, are increasingly being used to improve the performance and reduce the cost of a product. Such materials include nanoparticles, nanofilms and nanocomposites of organic (drugs and biopolymers) and inorganic (metal and ceramic) materials. In the future, the assembly and organisation of nanomaterials to yield nanodevices and nanosystems possessing increasingly complex functions will be important. Examples of improved products and processes include secure printing inks (nanoparticle), self-cleaning windows (nanostructured film) and harder wearing tyres (nanocomposite). For a company to use nanotools and nanomaterials to improve its existing products and processes it will be necessary that the above tools and materials are readily available from a reputable commercial source. It will generally be the case that a company’s manufacturing process will be readily adapted to accommodate the use of the above nanotools and nanomaterials. It is expected that the investment in improving a product or process will be recovered in the form of maintained or improved market share. Increased margins may, however, be quickly eroded by the competitive response; unless, the initial competitive advantage can be maintained by establishing ownership of the relevant intellectual property.
Page 1 and 2: I C STI I R E L A N D Irish Council
Page 3 and 4: FUNCTIONS OF THE IRISH COUNCIL FOR
Page 5 and 6: 2 CONTENTS 6.5 Healthcare - Medical
Page 7 and 8: 4 1.0 EXECUTIVE SUMMARY Knowledge e
Page 9 and 10: 6 Nanotechnology - National Roadmap
Page 11 and 12: 8 Assuming that the recommendations
Page 13 and 14: 10 A significant increase in the nu
Page 15 and 16: 12 2.0 INTRODUCTION 2.1 Background
Page 17 and 18: 14 2.5 Acknowledgements The Council
Page 19 and 20: 16 and lowered as it scans across t
Page 21 and 22: 18 Figure 3.3: Nanocrystals of the
Page 23 and 24: 20 4.0 ROADMAP 4.1 Background The n
Page 25 and 26: 22 4.4 Nanotechnology Enabled Produ
Page 27: 24 5.0 OPPORTUNITY 5.1 Background I
Page 31 and 32: 28 Figure 5.2: The launch of vehicl
Page 33 and 34: 30 An example of a multinational co
Page 35 and 36: 32 5.6 Conclusions Based on the abo
Page 37 and 38: 34 The above work for each sector w
Page 39 and 40: 36 Year of Production 2002 2004 200
Page 41 and 42: 38 Ireland should examine its curre
Page 43 and 44: 40 At the present time the photonic
Page 45 and 46: 42 6.4.2 Sector Roadmap From a tech
Page 47 and 48: 44 The growth of the medical device
Page 49 and 50: 46 Table 6.4: Challenges facing the
Page 51 and 52: 48 STAGE ONE: 1980 - 2000 STAGE TWO
Page 53 and 54: 50 it is possible that there will b
Page 55 and 56: 52 6.7.3 Intersection with Nanotech
Page 57 and 58: 54 6.8 Construction Sector 6.8.1 Se
Page 59 and 60: 56 More importantly, nanotechnology
Page 61 and 62: 58 7.0 CAPABILITY 7.1 Background Th
Page 63 and 64: 60 Higher Education Authority; thro
Page 65 and 66: 62 Enterprise Ireland is seeking to
Page 67 and 68: 64 Elan Corporation develops and ma
Page 69 and 70: 66 There are at least six establish
Page 71 and 72: 68 In respect of the second issue,
Page 73 and 74: 70 9.0 NATIONAL NANOTECHNOLOGY FORU
Page 75 and 76: 72 9.3 Conclusions The immediate es
Page 77 and 78: 74 The co-ordination of the funding
Page 79 and 80:
76 10.4 Conclusions The above strat
Page 81 and 82:
78 APPENDIX II Appendix II: Task Fo
Page 83 and 84:
80 Wednesday, 5th March 2003, Gover
Page 85 and 86:
82 Europe - Commission Nanotechnolo
Page 87 and 88:
84 Another important aspect of fund
Page 89 and 90:
86 Enterprise Ireland has already d
Page 91 and 92:
88 2. What is Nanotechnology? Nanot
Page 93 and 94:
90 For example the application of n
Page 95 and 96:
92 3.1.1 Electronics The electronic
Page 97 and 98:
94 3.2. Market development timescal
Page 99 and 100:
96 There are two start-up nanotechn
Page 101 and 102:
98 4.3 Established EI Clients A num
Page 103 and 104:
100 6. Primary targets for the deve
Page 105 and 106:
102 Objective 3. Increase the numbe
Page 107 and 108:
104 Objective 7. Assist researchers
Page 109 and 110:
106 Potential industrial adopters n
Page 111 and 112:
108 Section 2 - National and Intern
Page 113 and 114:
110 ii. Technology Development Rese
Page 115 and 116:
112 UCD Prof. Donald 961,000 Using
Page 117 and 118:
114 5. European Union Funding via F
Page 119 and 120:
116 UCD HPMD-CT-2000-00014 0.45 Cha
Page 121 and 122:
118 Communications Communications i
Page 123 and 124:
120 (b) SMEs that are inventors of
Page 125 and 126:
122 Dr. Pat Morgan Dean, Faculty of
Page 127 and 128:
124 A Partnership Approach to Resea
Page 129:
July 2004
show all

ICSTI Statement on Nanotechnology - Forfás

Create successful ePaper yourself

Delete template?

Save as template?